三月 2026
sentibio.com
显示 Similarweb 估计数据。
关联 GA4,公开验证您的网站指标
与您的成功同步
绑定 Google Analytics,验证您网站的流量及用户参与度指标
跳出率
42.49%
每次访问页数
1.83
平均访问时长
00:00:14
sentibio.com的 10 大竞争对手
在 三月 2026 与 sentibio.com 相似的前 10 名网站,按关键字流量、受众定位和市场重叠方面与 sentibio.com 的关联性排名
– Affini-T will leverage ElevateBio BaseCamp's LentiPeakTM lentiviral vector technology platform and cell product manufacturing capabilities to progress its
- 行业
- 不适用
跳出率
32.68%
每次访问页数
2.30
平均访问时长
00:00:46
相似度评分
100%Privacy policy This Privacy Policy describes the privacy practices of Erasca, Inc. (“Erasca”, “we”, “us” or “our”). Protecting the privacy and security of your personal information is important to Erasca. This Privacy Policy is designed to help you understand what data Erasca may collect, how Erasca uses and safeguards that data and who we may […]
跳出率
44.78%
每次访问页数
1.93
平均访问时长
00:01:46
相似度评分
97%European laws, including the General Data Protection Regulation (“GDPR”) and the e-Privacy Directive 2002/58/EC, create obligations for digital publishers such as Inozyme Pharma (“Inozyme”) to give visitors of their sites and apps information about how they will use and share their personal data, as well as about the use of cookies, mobile ad IDs, and […]
- 公司
- Inozyme
- 行业
- 不适用
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
85.48%
每次访问页数
1.59
平均访问时长
00:00:51
相似度评分
95%跳出率
41.9%
每次访问页数
1.58
平均访问时长
00:00:08
Kollab announced the acquisition of Senti AI, the pioneering artificial intelligence company in the Philippines. The acquisition of Senti AI coincides with Kollab's 10th year anniversary and reinforces their commitment to becoming a leading provider of AI-first and cloud-first solutions in the Philippines and across Southeast Asia.
- 公司
- - -
- 行业
- - -
跳出率
41.08%
每次访问页数
1.74
平均访问时长
00:00:45
相似度评分
89%The modern scientific enterprise is in the age of data science, utilizing advancing tools like computational biology, machine learning & AI.
跳出率
49.59%
每次访问页数
1.97
平均访问时长
00:01:55
The recent invalidation of an AAV gene therapy patent overlooks the complexity of innovation in biotechnology and could put a broad swath of intellectual property at risk.
- 公司
- - -
- 行业
- - -
跳出率
66.8%
每次访问页数
2.19
平均访问时长
00:01:49
Learn about Kite’s mission to change the way cancer is treated with cell therapy – the use of genetically modified immune cells programmed to target tumors.
跳出率
45.79%
每次访问页数
1.63
平均访问时长
00:00:54
The extraordinary general meeting (“EGM”) of the shareholders of CureVac N.V. will take place on Tuesday, March 28, 2023, starting from 2 p.m. Central European Summer Time.
跳出率
43.7%
每次访问页数
1.43
平均访问时长
00:00:21
相似度评分
79%Transforming disease treatment through cell and gene therapy. Join us at BlueRock to discover our cutting-edge science & clinical programs.
跳出率
49.47%
每次访问页数
1.70
平均访问时长
00:00:45
sentibio.com在 三月 2026 的前五名竞争对手是:affinittx.com、erasca.com、inozyme.com、regenxbio.com等。
根据 Similarweb 的月访问量数据,sentibio.com 在 三月 2026 的头号竞争对手是 affinittx.com。与 sentibio.com 相似度排名第二的网站是 erasca.com,排名第三的是 inozyme.com。
在 三月 2026,regenxbio.com 被评为与 sentibio.com 相似度第四高的网站,senti.ai 位居第五。
进入前十名榜单的其他五家竞争对手分别是 sbpdiscovery.org、biospace.com、kitepharma.com、curevac.com 和 bluerocktx.com。